Joint Commission International的动态

?? New ACTION publication ?? Using data from the ACTION registry, authors reviewed outcomes for patients who received Impella pumps alongside VA-ECMO from 2014 to 2021. The results? Out of 20 patients, 45% recovered, 40% moved to durable VADs, and 5% got heart transplants. These findings suggest Impella support could be vital for older pediatric patients to help their hearts recover or prepare for the next steps in treatment. Learn more about their study here: https://bit.ly/3ysUpfD! #PedsHF #PedsVAD

Dyspnea can cause major discomfort and distress. Learn to help your patients manage breathlessness with wholistic, evidence-based pharmacological and non-pharmacological approaches to treatment in our Online On-Demand course. Enroll today to start anytime in our Self-Directed course. #HealthcareEducation #Dyspnea #ContinuingEducation

Midday patient volume surges, misalignment between nurse staffing and daily patient appointment volume, and an uneven cadence of appointment starts kept Oklahoma Cancer Specialists and Research Institute from reaching its care delivery goals. Now, nearly two years after implementing iQueue for Infusion Centers, our partners at OCSRI have achieved sustainable, transformative results including: ?? 21% increase in average daily completed volume ? 23% increase in average daily completed patient hours ?? 14% decrease in average daily infusion wait time during peak hours Follow along their journey to improved patient and staff experience: https://bit.ly/3HQNqP0

Dyspnea can cause major discomfort and distress. Learn to help your patients manage breathlessness with wholistic, evidence-based pharmacological and non-pharmacological approaches to treatment in our Online On-Demand course. Enroll today to start anytime in our Self-Directed course. #HealthcareEducation #Dyspnea #ContinuingEducation

The addition of dapagliflozin to standard care for critically ill patients and acute organ dysfunction did not improve clinical outcomes; however, confidence intervals were wide and could not exclude relevant benefits or harms for dapagliflozin. The primary outcome was a hierarchical composite of hospital mortality, initiation of kidney replacement therapy, and ICU length of stay through 28 days, analyzed using the win ratio method. Secondary outcomes included the individual components of the hierarchical outcome, duration of organ support–free days, ICU, and hospital stay, assessed using bayesian regression models.

Why not take some time today for CME/CE? There is emerging research on the pathophysiology of aHUS. Get up to speed on diagnosis and state-of-the-art treatments and hear about the perspectives unique to pediatric vs adult care. Register: https://bit.ly/3zVDdjI

our newly indicated advanced hemodynamic monitoring solutions for pediatric patients!

Use of low-dose protocols may result in lower computer-aided detection-system performance for lung nodule detection in pediatric patients, although the impact on detection varies between systems. https://lnkd.in/ghFVBtih

Yesterday, Regen Med hosted their first patient support and advocacy group at the clinic. We talked about their journey navigating the healthcare system and their challenges to diagnosis and treatment. Myasthenia Gravis, an autoimmune neurological disorder, causes localized and generalized muscle that often goes undiagnosed for years. And adding insult to injury, patients are not educated about all the treatment options available to them, including Therapeutic Apheresis, particularly Therapeutic Plasma Exchange (TPE). TPE is a vital treatment for managing myasthenia gravis (MG), especially during crises. While traditionally gate-kept by hospitals, TPE can be safely administered outside the hospital, offering flexibility and comfort for stable patients needing chronic treatment of TPE. Of course, I continue to advocate for TPE to be performed by physicians that have the medical education, training, and fellowship to perform the procedures. This shift empowers patients to manage their condition more effectively while maintaining their daily routines. Let’s advocate for wider access to outpatient-based, non-hospital associated TPE, ensuring all MG patients and other patients with autoimmune disorders receive timely and convenient care. Together, we can enhance quality of life and treatment outcomes for those living with autoimmune disorder, including MG. Thank you to the Myasthenia Gravis Association for their groundbreaking efforts for MG patients. #PatientAdvocacy #MyastheniaGravis #outpatientcare #autoimmunedisorders #patienteducation #therapeuticplasmaexchange #therapeuticaphersis #nonhospitalbasedcare #insurancechangesrequired